FRA:EUZ - Deutsche Boerse Ag - DE0005659700 - Common Stock - Currency: EUR
FRA:EUZ (7/3/2025, 5:29:46 PM)
66.75
+0.2 (+0.3%)
The current stock price of EUZ.DE is 66.75 EUR. In the past month the price increased by 1.6%. In the past year, price increased by 44.55%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABL.DE | ABBOTT LABORATORIES | 28 | 198.27B | ||
IUI1.DE | INTUITIVE SURGICAL INC | 70.72 | 164.75B | ||
1ISRG.MI | INTUITIVE SURGICAL INC | 67.95 | 158.31B | ||
BSX.DE | BOSTON SCIENTIFIC CORP | 37.91 | 129.01B | ||
2M6.DE | MEDTRONIC PLC | 16.05 | 96.33B | ||
SHL.DE | SIEMENS HEALTHINEERS AG | 20.77 | 52.94B | ||
BOX.DE | BECTON DICKINSON AND CO | 12.62 | 43.38B | ||
EWL.DE | EDWARDS LIFESCIENCES CORP | 29.33 | 38.02B | ||
DC4.DE | DEXCOM INC | 51.04 | 28.02B | ||
PHI1.DE | KONINKLIJKE PHILIPS NV | 15.02 | 19.49B | ||
PHIA.AS | KONINKLIJKE PHILIPS NV | 14.93 | 19.36B | ||
1PHIA.MI | KONINKLIJKE PHILIPS NV | 14.89 | 19.32B |
Eckert & Ziegler SE is a holding company, which engages in the processing of radio isotopes. The company is headquartered in Berlin, Berlin and currently employs 1,085 full-time employees. The firm operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
ECKERT & ZIEGLER SE
Robert-Roessle-Str.10
Berlin BERLIN DE
Employees: 1085
Phone: 49309410840
The current stock price of EUZ.DE is 66.75 EUR. The price increased by 0.3% in the last trading session.
The exchange symbol of ECKERT & ZIEGLER SE is EUZ and it is listed on the Deutsche Boerse Ag exchange.
EUZ.DE stock is listed on the Deutsche Boerse Ag exchange.
6 analysts have analysed EUZ.DE and the average price target is 68.9 EUR. This implies a price increase of 3.22% is expected in the next year compared to the current price of 66.75. Check the ECKERT & ZIEGLER SE stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ECKERT & ZIEGLER SE (EUZ.DE) has a market capitalization of 1.41B EUR. This makes EUZ.DE a Small Cap stock.
ECKERT & ZIEGLER SE (EUZ.DE) currently has 1085 employees.
ECKERT & ZIEGLER SE (EUZ.DE) has a support level at 65.5 and a resistance level at 67.86. Check the full technical report for a detailed analysis of EUZ.DE support and resistance levels.
The Revenue of ECKERT & ZIEGLER SE (EUZ.DE) is expected to grow by 8.94% in the next year. Check the estimates tab for more information on the EUZ.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ECKERT & ZIEGLER SE (EUZ.DE) has a dividend yield of 0.75%. The yearly dividend amount is currently 0.05. Check the full fundamental report for a detailed analysis of EUZ.DE dividend history, reliability and sustainability.
ECKERT & ZIEGLER SE (EUZ.DE) will report earnings on 2025-08-08.
The PE ratio for ECKERT & ZIEGLER SE (EUZ.DE) is 40.95. This is based on the reported non-GAAP earnings per share of 1.63 and the current share price of 66.75 EUR. Check the full fundamental report for a full analysis of the valuation metrics for EUZ.DE.
ChartMill assigns a technical rating of 10 / 10 to EUZ.DE. When comparing the yearly performance of all stocks, EUZ.DE is one of the better performing stocks in the market, outperforming 94.81% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to EUZ.DE. Both the health and profitability get an excellent rating, making EUZ.DE a very profitable company, without any liquidiy or solvency issues.
Over the last trailing twelve months EUZ.DE reported a non-GAAP Earnings per Share(EPS) of 1.63. The EPS increased by 14.59% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 11.63% | ||
ROA | 7.63% | ||
ROE | 14.94% | ||
Debt/Equity | 0.19 |
ChartMill assigns a Buy % Consensus number of 80% to EUZ.DE. The Buy consensus is the average rating of analysts ratings from 6 analysts.
For the next year, analysts expect an EPS growth of 25% and a revenue growth 8.94% for EUZ.DE